To assess the potential impact of decreased JADE2 mRNA expression on tumor immunity, an analysis of tumor-infiltrating immune cells (TIICs) in NSCLC was conducted using TIMER [54]. The gene discussed is JADE2; the disease is non-small cell lung carcinoma.